(1) If an * R&D entity is entitled under section 355 - 100 to a * tax offset for an income year for expenditure it can deduct under section 355 - 205, 355 - 480 or 355 - 580, that expenditure:
(a) cannot be taken into account by any entity in working out a deduction under any other Division of this Act for any income year; and
(b) cannot be taken into account by any entity in working out a tax offset under any other Division of this Act for any income year.
Note: Section 355 - 205 is about R&D expenditure, section 355 - 480 is about earlier year associate R&D expenditure, and section 355 - 580 is about CRC contributions.
(2) If an * R&D entity is entitled under section 355 - 100 to a * tax offset for an income year for a deduction under section 355 - 305 or 355 - 520 of an amount equal to the decline in value of an asset, that decline in value:
(a) cannot be taken into account by any entity in working out a deduction under any other Division of this Act (other than section 40 - 292 or 40 - 293) for any income year; and
(b) cannot be taken into account by any entity in working out a tax offset under any other Division of this Act for any income year;
to the extent that the decline in value is attributable to the use of the asset for the purpose of conducting one or more of the * R&D activities to which the deduction relates.
Note 1: A deduction may be available under section 40 - 25 to the extent that the asset's decline in value is attributable to another purpose. If so, that deduction under section 40 - 25 will not take into account the asset's decline in value to the extent that it is attributable to the R&D activities (see also subsection 40 - 25(2)).
Note 2: Section 355 - 305 is about the decline in value of R&D assets and section 355 - 520 is about the decline in value of R&D partnership assets.
Note 3: Sections 40 - 292 and 40 - 293 deal with balancing adjustments when deductions have been available for the asset's decline in value both under this Division and section 40 - 25.
Table of Subdivisions
360 - A Tax incentives for early stage investors in innovation companies